Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BVS
CRVS
Add up to 3 more stocks
BVS
Bioventus Inc.
-1.96%
$13.25-0.27Delayed quote: Oct 6, 2026, 2:35 PM EDT
Market Cap
$897.97M
52W Range
$6.37 - $15.89
CRVS
Corvus Pharmaceuticals, Inc.
-2.78%
$10.44-0.30Delayed quote: Oct 6, 2026, 2:35 PM EDT
Market Cap
$877.99M
52W Range
$6.39 - $26.95
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 17.21 | N/A |
| Forward P/E | 17.02 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.93 | 3.90 |
| P/S Ratio | 1.54 | N/A |
| P/FCF Ratio | 9.52 | N/A |
| EV/EBITDA | 10.57 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 68.0% | 0.0% |
| Operating Margin | 10.6% | 0.0% |
| Net Margin | 9.4% | 0.0% |
| ROE | 23.9% | -24.0% |
| ROA | 8.1% | -22.6% |
| ROIC | 11.4% | -25.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.69 | 16.16 |
| Quick Ratio | 1.17 | 16.16 |
| Debt/Equity | 1.16 | 0.00 |
| Interest Coverage | 2.21 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.